Loreto Gesualdo

Active 1989–2026

292
Papers
25,602
Citations
93
h-index
268
i10-index

Citations

Citations per year for Loreto Gesualdo1967: 1 citations1990: 2 citations1991: 2 citations1992: 12 citations1993: 14 citations1994: 10 citations1995: 18 citations1996: 17 citations1997: 17 citations1998: 25 citations1999: 40 citations2000: 39 citations2001: 37 citations2002: 42 citations2003: 48 citations2004: 45 citations2005: 49 citations2006: 52 citations2007: 76 citations2008: 90 citations2009: 104 citations2010: 74 citations2011: 93 citations2012: 126 citations2013: 124 citations2014: 125 citations2015: 139 citations2016: 144 citations2017: 164 citations2018: 202 citations2019: 654 citations2020: 941 citations2021: 1,148 citations2022: 953 citations2023: 855 citations2024: 1,411 citations2025: 674 citations2026: 18 citations1968–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,101 citing papers, 18.7% of this breakdownChina: 1,548 citing papers, 13.8% of this breakdownItaly: 1,118 citing papers, 10% of this breakdownUnited Kingdom: 601 citing papers, 5.4% of this breakdownGermany: 554 citing papers, 4.9% of this breakdownFrance: 403 citing papers, 3.6% of this breakdownSpain: 355 citing papers, 3.2% of this breakdownJapan: 340 citing papers, 3% of this breakdownNetherlands: 293 citing papers, 2.6% of this breakdownCanada: 287 citing papers, 2.6% of this breakdownAustralia: 266 citing papers, 2.4% of this breakdownIndia: 195 citing papers, 1.7% of this breakdown
0%18.7%Other 28.1%

Fields

  • Medicine66.3%
  • Biochemistry, Genetics and Molecular Biology18.3%
  • Immunology and Microbiology5.5%
  • Neuroscience4%
  • Computer Science1.7%
  • Nursing0.9%
  • Other3.3%

Topics

  • Renal Diseases and Glomerulopathies6.7%
  • Chronic Kidney Disease and Diabetes5.5%
  • Dialysis and Renal Disease Management2.4%
  • Gut microbiota and health2%
  • Acute Kidney Injury Research1.7%
  • Renal and related cancers1.6%
  • Other80.1%

Coauthors

All papers

Open in search
  1. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Muh Geot Wong, Vlado Perkovic, Isabella Abbasciano, Catarina Abrantes, Simone Accarino, Sharon G. Adler, Annika Adoberg, Rouzbeh Afsari, Syeda B. Ahmad, Jafar Ahmed, Wooin Ahn, Bamidele Ajayi, Dariusz Aksamit, Saif Al‐Chalabi, É. Alamartine, Bassam Alchi, Mohammad Ali, Roberta Aliotta, Salem Almaani, Catarina Almeida, Edgar Almeida, Francisco de la Prada Álvarez, Patrícia Marques‐Alves, Francesca Annese, Gerald B. Appel, Gerald Appel, Maria Arena, Marta Calvo Arevalo, Dariush Arfaania, Carlos Arias, Emma Calatayud Aristoy, Eglė Ašakienė, Sarah Ashley, Ali Assefi, Alba Atenza, Asta Auerbach, Hanna Augustyniak‐Bartosik, Hanna Augustyniak-Bartosik, Jonathan Ayling-Smith, Isabelle Ayoub, Isabelle Ayoub, Rocco Baccaro, Asha Bailey, Bruce Baker, Saravanan Balamuthusamy, José Ballarín, Rui Barata, Jerko Barbić, Dunja Barisic, Jonathan Barratt, José C. Barreto, Clara Barrios, Mirco Belingheri, Anna Benesova, Ana Ávila Bernabéu, Wanja Bernhardt, Shamik Bhadra, Luigi Biancone, Anne Blanchard, Elena Boaglio, Davide Bolignano, Andrew S. Bomback, Gustavo Andres Useche Bonilla, M Bordoli, Bhadran Bose, Neil Boudville, Donald Brandon, Donald Brandon, Karen Brown, C Broyet and 634 more - The Lancet 2023 cited by 267

  2. Autoantibodies Targeting Nephrin in Podocytopathies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Pierre Ronco, Marina Vivarelli, Loreto Gesualdo, Nicola M Tomas, Tobias B. Huber - New England Journal of Medicine 2024 cited by 245

  3. Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Évangéline Pillebout, Renato C. Monteiro, Raoul D. Nelson, Robert Wyatt, William E. Smoyer, John D. Mahan, Al-Akash Samhar, Guillermo Hidalgo, Alejandro Quiroga, Patricia L. Weng, Raji Sreedharan, David T. Selewski, Keefe Davis, Mahmoud Kallash, Tetyana L. Vasylyeva, Michelle N. Rheault, Aftab S. Chishti, Daniel Ranch, Scott E. Wenderfer, Dmitry Samsonov, Donna Claes, Oleh M. Akchurin, Dimitrios Goumenos, Μaria Stangou, Judit Nagy, Tibor Kovács, Enrico Fiaccadori, Antonio Amoroso, Cristina Barlassina, Daniele Cusi, Lucia Del Vecchio, Giovanni Giorgio Battaglia, Monica Bodria, Emanuela Boer, Luisa Bono, Giuliano Boscutti, Gianluca Caridi, Francesca Lugani, Gian Marco Ghiggeri, Rosanna Coppo, Licia Peruzzi, Vittoria Esposito, Ciro Esposito, Sandro Feriozzi, Rosaria Polci, Giovanni M. Frascà, Marco Galliani, Maurizio Garozzo, Adele Mitrotti, Loreto Gesualdo, Simona Granata, Gianluigi Zaza, Francesco Londrino, Riccardo Magistroni, Isabella Pisani, Andrea Magnano, Carmelita Marcantoni, Piergiorgio Messa, Renzo Mignani, Antonello Pani, Claudio Ponticelli, Dario Roccatello, Maurizio Salvadori, Erica Salvi, Domenico Santoro, Guido Gembillo, Silvana Savoldi, Donatella Spotti, Pasquale Zamboli, Claudia Izzi and 88 more - Nature Genetics 2023 cited by 172

  4. Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gianluca Caridi, Monica Bodria, Francesca Lugani, Landino Allegri, Marco Delsante, Mariarosa Maiorana, Andrea Magnano, Giovanni M. Frascà, Emanuela Boer, Giuliano Boscutti, Claudio Ponticelli, Renzo Mignani, Carmelita Marcantoni, Domenico Di Landro, Domenico Santoro, Antonello Pani, Rosaria Polci, Sandro Feriozzi, Silvana Chicca, Marco Galliani, Maddalena Gigante, Loreto Gesualdo, Pasquale Zamboli, Giovanni Giorgio Battaglia, Maurizio Garozzo, Dita Maixnerová, Vladimı́r Tesař, Frank Eitner, Thomas Rauen, Jürgen Floege, Tibor Kovács, Judit Nagy, Krzysztof Mucha, Leszek Pączek, Marcin Zaniew, Małgorzata Mizerska-Wasiak, Maria Roszkowska–Blaim, Krzysztof Pawlaczyk, Daniel P. Gale, Jonathan Barratt, Lise Thibaudin, F. Berthoux, Guillaume Canaud, Anne Boland, Marie Metzger, Ulf Panzer, Hitoshi Suzuki, Shin Goto, Ichiei Narita, Yaşar Çalışkan, Jingyuan Xie, Ping Hou, Nan Chen, Hong Zhang, Robert Wyatt, Jan Novák, Bruce A. Julian, John Feehally, Bénédicte Stengel, Daniele Cusi, Richard P. Lifton, Ali G. Gharavi - Nature Genetics 2014 cited by 626

  5. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anna Maria Asunis, Jonathan Barratt, Regina Tardanico, Agnieszka Perkowska‐Ptasińska - Kidney International 2014 cited by 496

  6. The mucosal immune system and IgA nephropathy

    Authors: , , - Seminars in Immunopathology 2021 cited by 147

  7. Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 cited by 105

  8. The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Agnieszka Perkowska‐Ptasińska, Magdalena Durlik, Krzysztof Mucha, Barbara Moszczuk, Bartosz Foroncewicz, Leszek Pączek, Ireneusz Habura, Elisabet Ars, José Ballarín, Laila-Yasmin Mani, Bruno Vogt, Savaş Öztürk, Abdülmecit Yıldız, Nurhan Seyahi, Hakkı Arikan, Mehmet Koç, Taner Baştürk, Gonca E. Karahan, Sebahat Usta Akgül, Mehmet Şükrü Sever, Dan Zhang, Domenico Santoro, Mario Bonomini, Francesco Londrino, Loreto Gesualdo, Jana Reiterová, Vladimı́r Tesař, Claudia Izzi, Silvana Savoldi, Donatella Spotti, Carmelita Marcantoni, Piergiorgio Messa, Marco Galliani, Dario Roccatello, Simona Granata, Gianluigi Zaza, Francesca Lugani, Gian Marco Ghiggeri, Isabella Pisani, Landino Allegri, Ben Sprangers, Jin‐Ho Park, Belong Cho, Yon Su Kim, Dong Ki Kim, Hitoshi Suzuki, Antonio Amoroso, Daniel Cattran, Fernando C. Fervenza, Antonello Pani, Patrick Hamilton, Shelly Harris, Sanjana Gupta, Chris Cheshire, Stephanie Dufek, Naomi Issler, Ruth J. Pepper, John Connolly, Stephen H. Powis, Detlef Böckenhauer, Horia Stanescu, Neil Ashman, Ruth J. F. Loos, Eimear E. Kenny, Matthias Wuttke, Kai‐Uwe Eckardt, Anna Köttgen, Julia M. Hofstra, Marieke J. H. Coenen, Lambertus A. Kiemeney and 20 more - Nature Communications 2020 cited by 220

  9. Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2021 cited by 243

  10. Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ferruccio Galletti, Claudio Ferri, Giovambattista Desideri, Francesca Viazzi, Roberto Pontremoli, María Lorenza Muiesan, Guıdo Grassı, Claudio Borghi, from the Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension - Hypertension 2019 cited by 266

  11. Brain neural synchronization and functional coupling in Alzheimer's disease as revealed by resting state EEG rhythms

    Authors: , , , , , , , , - International Journal of Psychophysiology 2015 cited by 361

  12. An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients

    Authors: , , , , , , , , , , , , - Toxins 2021 cited by 66

  13. Obesity-Related Chronic Kidney Disease: Principal Mechanisms and New Approaches in Nutritional Management

    Authors: , , , , , , , - Frontiers in Nutrition 2022 cited by 95

  14. PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma

    Authors: , , , , , , , , , , , , , - Aging 2020 cited by 172

  15. Association between Long COVID and Overweight/Obesity

    Authors: , , , , , , , , , , , , , - Journal of Clinical Medicine 2021 cited by 142

  16. Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma

    Authors: , , , , , , , , , , - International Journal of Molecular Sciences 2023 cited by 98

  17. Recent advances in the pathogenetic mechanisms of sepsis-associated acute kidney injury

    Authors: , , , , , , , - Journal of Nephrology 2017 cited by 206

  18. The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?

    Authors: , , , , , , , - Frontiers in Immunology 2020 cited by 205

  19. Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yuan Luo, Wei‐Qi Wei, QiPing Feng, Chunhua Weng, Yilu Fang, Iftikhar J. Kullo, Mohammadreza Naderian, Nita A. Limdi, Marguerite R. Irvin, Hemant K. Tiwari, Sumit Mohan, Maya K. Rao, Geoffrey K. Dube, Ninad S. Chaudhary, Orlando M. Gutiérrez, Suzanne E. Judd, Mary Cushman, Leslie A. Lange, Ethan M. Lange, Daniel L. Bivona, Miguel Verbitsky, Cheryl A. Winkler, Jeffrey B. Kopp, Dominick Santoriello, Ibrahim Batal, Sérgio Veloso Brant Pinheiro, Eduardo A. Oliveira, Ana Cristina Simões e Silva, Isabella Pisani, Enrico Fiaccadori, Fangming Lin, Loreto Gesualdo, Antonio Amoroso, Gian Marco Ghiggeri, Vivette D. D’Agati, Riccardo Magistroni, Eimear E. Kenny, Ruth J. F. Loos, Giovanni Montini, Friedhelm Hildebrandt, Dirk S. Paul, Slavé Petrovski, David B. Goldstein, Matthias Kretzler, Rasheed Gbadegesin, Ali G. Gharavi, Krzysztof Kiryluk, Matthew G. Sampson, Martin R. Pollak, Simone Sanna‐Cherchi - Nature Communications 2023 cited by 68

  20. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease

    Authors: , , , , - Current Diabetes Reports 2017 cited by 200

  21. Nutritional Therapy Modulates Intestinal Microbiota and Reduces Serum Levels of Total and Free Indoxyl Sulfate and P-Cresyl Sulfate in Chronic Kidney Disease (Medika Study)

    Authors: , , , , , , , , , , , , - Journal of Clinical Medicine 2019 cited by 132

  22. Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle?

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dimitrios Goumenos, Ayşe Tuğba Kartal, Laila‐Yasmin Mani, Hans-Peter Marti, Christopher Mayer, Rikke Nielsen, Vesna Pešić, Merita Rroji, Giorgos K. Sakkas, Goce Spasovski, Kate Stevens, Evgueniy Vazelov, Davide Viggiano, Lefteris C. Zacharia, Ana Carina Ferreira, Jolanta Malyszko, Ewout J. Hoorn, Andreja Figurek, Robert J. Unwin, Carsten A. Wagner, Christoph Wanner, Annette Bruchfeld, Marion Pépin, Andrzej Więcek, Dorothea Nitsch, Ivo Fridolin, Gaye Hafez, María José Soler Romeo, Michelangela Barbieri, Bojan Batinić, Laura Carrasco, Sol Carriazo, Ron T. Gansevoort, Gianvito Martino, Francesco Mattace‐Raso, Ionuţ Nistor, Alberto Ortíz, Giuseppe Paolisso, Daiva Rastenytė, Gabriel Ştefan, Gioacchino Tedeschi, Ziad A. Massy, Boris Bikbov, Karlhans Endlich, Olivier Godefroy, Jean‐Marc Chillon, Anastassia Kossioni, Justina Kurganaite, Norberto Perico, Giuseppe Remuzzi, Tomasz Grodzicki, Francesco Trepiccione, Carmine Zoccali, Mustafa Arıcı, Peter J. Blankestijn, Kai‐Uwe Eckardt, Danilo Fliser, Eugenio Gutiérrez Jiménez, Maximilian König, Ivan Rychlík, Michela Deleidi, György Reusz - Nephrology Dialysis Transplantation 2021 cited by 90

  23. DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2018 cited by 182

  24. GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: state of the art

    Authors: , , , , , , , - Clinical Kidney Journal 2022 cited by 51